Analyses of a Subset of Patients with Primary Immunodeficiency Diseases (PIDD) Who Switched Modes of Administration of Immunoglobulin (Ig) Therapy during Three Consecutive Studies

Ig therapies for PIDD are available in different administration modes, characterized by their pharmacokinetics, infusion parameters, and tolerability. We report the efficacy and tolerability data for a subset of 31 patients with PIDD who switched modes of Ig therapy during three consecutive studies.